STABILIZED FORMULATIONS CONTAINING ANTI-INTERLEUKIN-6 RECEPTOR (IL-6R) ANTIBODIES

摘要

PROBLEM TO BE SOLVED: To provide pharmaceutical formulations comprising a human antibody that specifically binds to human interleukin-6 receptor (hIL-6R).SOLUTION: The pharmaceutical formulations contain, in addition to an anti-hIL-6R antibody, at least one amino acid, at least one sugar, and/or at least one non-ionic surfactant. The pharmaceutical formulations exhibit a substantial degree of antibody stability after storage for several months.SELECTED DRAWING: None